Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
1(25%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_4
1
25%
Ph phase_3
1
25%

Phase Distribution

0

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution2 total trials
Phase 3Large-scale testing
1(50.0%)
Phase 4Post-market surveillance
1(50.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Completed(2)
Other(1)

Detailed Status

Completed2
unknown1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 31 (50.0%)
Phase 41 (50.0%)

Trials by Status

completed250%
unknown125%
recruiting125%

Recent Activity

1 active trials
Showing 4 of 4
recruiting

Maternal And Infant Antipsychotic Study

NCT06049953
completedphase_3

A Study to Evaluate Efficacy and Safety of Bitopertin in Participants With Persistent, Predominant Negative Symptoms of Schizophrenia

NCT01192880
completed

A Registry of Treatment Adherence for Patients With Schizophrenia

NCT00283517
unknownphase_4

Identifying Predictors of Response to Antipsychotics Using a Treatment Algorithm

NCT01016145

Clinical Trials (4)

Showing 4 of 4 trials
NCT06049953

Maternal And Infant Antipsychotic Study

Recruiting
NCT01192880Phase 3

A Study to Evaluate Efficacy and Safety of Bitopertin in Participants With Persistent, Predominant Negative Symptoms of Schizophrenia

Completed
NCT00283517

A Registry of Treatment Adherence for Patients With Schizophrenia

Completed
NCT01016145Phase 4

Identifying Predictors of Response to Antipsychotics Using a Treatment Algorithm

Unknown

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4